Quality of life and cost-effectiveness in patients undergoing level I versus level II and III axillary lymph node dissection for breast cancer: A double blind randomised controlled trial with non-inferiority hypothesis

Category Primary study
JournalCANCER RESEARCH
Year 2019
This article has no abstract
Epistemonikos ID: a7f722726c9cbe7da0d60b617460a54862e23a47
First added on: Feb 10, 2025